Review of New and Emerging Therapies that Improve Tolerability and Adherence in Patients with Relapsing Multiple Sclerosis

Mar 23, 2024

- Mar 22, 2025

0.75

Claim your AMA PRA Category 1 Credit(s)

This course is available for logged in users only. Please login or register to take the course.

Obstructive Hypertrophic Cardiomyopathy: Evidence-Based, Specific Pathology-Targeted Manag...

LIVE UPDATE FROM ACC25: More Support for the “Factor XI Hypothesis”

MANAGEMENT OF PSVT: UPDATE FROM ACC25